CC-3, an IgG-based B7-H3xCD3 bispecific antibody for targeting of gastrointestinal cancers

被引：0

作者：

Zekri, Latifa ^{[1
]}

Lutz, Martina S. ^{[1
]}

Hagelstein, Ilona ^{[1
]}

Manz, Timo ^{[2
]}

Engel, Monika ^{[1
]}

Klimovich, Boris ^{[1
]}

Prakash, Nisha ^{[1
]}

Chashchina, Anna ^{[1
]}

Hoerner, Sebastian ^{[1
]}

Mueller, Stefanie ^{[1
]}

Maerklin, Melanie ^{[1
]}

Pfluegler, Martin ^{[1
]}

Jung, Gundram ^{[1
]}

Salih, Helmut R. ^{[1
]}

机构：

[1] German Canc Res Ctr DKTK, Tubingen, Germany

[2] Eberhard Karls Univ Tuebingen, Tubingen, Germany

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2865

引用

页数：1

共 50 条

[1] An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers
Zekri, Latifa
Lutz, Martina
Prakash, Nisha
Manz, Timo
Klimovich, Boris
Mueller, Stefanie
Hoerner, Sebastian
Hagelstein, Ilona
Engel, Monika
Chashchina, Anna
Uegler, Martin P. fl
Heitmann, Jonas S.
Jung, Gundram
Salih, Helmut R.
MOLECULAR THERAPY, 2023, 31 (04) : 1033 - 1045
[2] CC-3, an IgG-based bispecific antibody for targeting B7-H3 positive colorectal carcinoma
Engel, M.
Zekri, L.
Hagelstein, I
Manz, T.
Klimovich, B.
Chashchina, A.
Mueller, S.
Jung, G.
Salih, H. R.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 35 - 35
[3] IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer
Lutz, Martina S. S.
Zekri, Latifa
Wessling, Laura
Berchtold, Susanne
Heitmann, Jonas S. S.
Lauer, Ulrich M. M.
Jung, Gundram
Salih, Helmut R. R.
FRONTIERS IN IMMUNOLOGY, 2023, 14
[4] IgG based B7-H3xCD3 bispecific antibody for treatment of gynecological tumors
Greiner, Sarah Maria
Mauermann, Jonas
Lutz, Martina
Hagelstein, Ilona
Tobias, Engler
Koch, Andre
Andreas, Hartkopf
Sara, Brucker
Zekri, Latifa
Marklin, Melanie
CANCER RESEARCH, 2023, 84 (06)
[5] Generation and clinical development of an optimized B7-H3xCD3 bispecific antibody for treatment of colorectal and other gastrointestinal cancers
Heitmann, J. S.
Zekri, L.
Lutz, M.
Prakash, N.
Klimovich, B.
Mueller, S.
Hoerner, S.
Hagelstein, I.
Pfluegler, M.
Jung, G.
Salih, H.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 4 - 4
[6] The bispecific B7H3xCD3 antibody CC-3 induces T cell immunity against bone and soft tissue sarcomas
Holzmayer, Samuel J.
Liebel, Kai
Hagelstein, Ilona
Salih, Helmut R.
Maerklin, Melanie
FRONTIERS IN IMMUNOLOGY, 2024, 15
[7] A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL
Mehta, Naveen K.
Pfluegler, Martin
Meetze, Kristan
Li, Bochong
Sindel, Isabelle
Vogt, Fabian
Marklin, Melanie
Heitmann, Jonas S.
Kauer, Joseph
Osburg, Lukas
Zekri, Latifa
Buehring, Hans-Joerg
Mueller, Stefanie
Hoerner, Sebastian
Baeuerle, Patrick A.
Michaelson, Jennifer S.
Jung, Gundram
Salih, Helmut R.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
[8] Development of an IgG based, bispecific antibody with FLT3xCD3-specificity for the treatment of myeloid leukemia
Vogt, F.
Ehnes, I.
Pfluegler, M.
Bhring, H. -J.
Salih, H.
Jung, G.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 9 - +
[9] Construction, expression and identification of bispecific antibody for targeting CD3 and B7-H3.
Zhang, K.
Gui, F.
Wang, J.
Pan, Y.
Yang, X.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1743 - 1743
[10] Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)
Jung, Susanne
Schlenk, Richard F.
Hackenbruch, Christopher
Pinzon, Sandra S. L. Roldan
Bitzer, Michael
Pfluegler, Martin
Walz, Juliane S.
Jung, Gundram
Heitmann, Jonas S.
Salih, Helmut R.
FRONTIERS IN ONCOLOGY, 2024, 14

← 1 2 3 4 5 →